BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37852835)

  • 1. Using MammaPrint on core needle biopsy to guide the need for axillary staging during breast surgery.
    Drapalik LM; Miller ME; Rock L; Li P; Simpson A; Shenk R; Amin AL
    Surgery; 2024 Mar; 175(3):579-586. PubMed ID: 37852835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omitting axillary staging in selected patients: Rationale of Choosing Wisely in breast cancer treatment.
    Grossi S; Le J; Armani A
    Surgery; 2023 Aug; 174(2):413-415. PubMed ID: 37169614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
    Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
    Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
    Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
    Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
    Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary dissection in sentinel lymph node positive breast cancer: Is the staging information worthwhile for patients?
    Chang DW; Bressel M; Hansen C; Blinman P; Schofield P; Chua BH
    Asia Pac J Clin Oncol; 2021 Apr; 17(2):e27-e34. PubMed ID: 31461222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
    Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
    Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-needle aspiration biopsy of axillary lymph nodes: A reliable diagnostic tool for breast cancer staging.
    Sallout L; Tashkandi M; Moqnas A; AlMajed H; Al-Naeem A; Alwelaie Y
    Cancer Cytopathol; 2024 Feb; 132(2):103-108. PubMed ID: 37843531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
    Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
    Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel Node Biopsy in Early Breast Cancer Patients with Palpable Axillary Node.
    Shojaee L; Abedinnegad S; Nafisi N; Naghshvar F; Godazandeh G; Moradi S; Shakeri Astani K; Godazandeh Y
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1631-1636. PubMed ID: 32592357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-negative frozen section of sentinel nodes in early breast cancer (cT1-2N0) patients.
    Loh ZJ; Lee KT; Chen YP; Kuo YL; Chung WP; Hsu YT; Huang CC; Hsu HP
    World J Surg Oncol; 2021 Jun; 19(1):183. PubMed ID: 34158071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era.
    Poodt IGM; Spronk PER; Vugts G; van Dalen T; Peeters MTFDV; Rots ML; Kuijer A; Nieuwenhuijzen GAP; Schipper RJ
    Ann Surg; 2018 Dec; 268(6):1084-1090. PubMed ID: 28742702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer.
    Nakamura R; Yamamoto N; Miyaki T; Itami M; Shina N; Ohtsuka M
    Breast Cancer; 2018 Jan; 25(1):86-93. PubMed ID: 28735457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Populations at Risk for "Choosing Un-Wisely": A SEER Population-Based Study.
    Hong MJ; Lum SS; Ji L; Namm JP; Solomon NL; Garberoglio C; Vora H
    Am Surg; 2023 Oct; 89(10):4135-4141. PubMed ID: 37259527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
    Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M
    J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt.
    Dominici LS; Sineshaw HM; Jemal A; Lin CC; King TA; Freedman RA
    Breast Cancer Res Treat; 2018 Jan; 167(2):555-566. PubMed ID: 28990127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.